Revance Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
The Compensation Committee of Revance’s Board of Directors approved the awards as an inducement material to the new employees’ employment in accordance with NASDAQ Listing Rule 5635(c)(4).
“Revance Therapeutics” and the Revance logo are registered trademarks of
RHA resilient hyaluronic acid® and RHA® are trademarks of
BOTOX® is a registered trademark of
Jenifer Slaw, 347-971-0906
Nadine Tosk, 504-453-8344